And D-dianhydromannitol monooleate (amphiphilic detergent) within Freund’s adjuvant partially restore receptor structural architecture by mimicking molecular interactions of the lipid bilayer cell membrane with receptors. 
Thus, polyclonal anti-GPCR IgG antibodies may include both antibodies able to bind to linear epitopes accessible in both native and denatured forms of the receptor and antibodies able to bind to conformational antigenic determinants preserved inDetection of endogenous receptorsThe ability of anti-GPCR IgG antibodies to recognize endogenous order 1418741-86-2 receptors was then investigated in human spermatozoids and human SH-SY5Y neuroblastoma cells in which the expression of MOR or KOR is well established [35,36,37]. AsAntibodies against G-Protein Coupled ReceptorsFigure 2. Binding of immune serum IgG to recombinant wild-type GPCRs expressed in CHO cells. The ability of immune serum IgG from mice immunized against hNPFFR2 (upper panels), hKOR (middle panels) and hMOR (lower panels) to specifically bind to their corresponding receptors (i.e. used for immunization) was assessed by order 69056-38-8 western-blotting (a), confocal immunofluorescence microscopy (b), and cytofluorometry (c). In (a), membrane proteins extracted from untransfected CHO-K1 cells (left lanes) or from CHO-K1 cells expressing either hNPFFR2 (hNPFFR2/CHO), hKOR (hKOR/CHO) or hMOR (hMOR/CHO) (right lanes) were run on SDS-polyacrylamide gel and transferred onto PVDF membrane. Protein extracts were probed with corresponding mouse immune sera. Bound IgG were revealed using horseradish peroxidase-labeled rabbit anti-mouse IgG antibodies. In (b), CHO cells expressing wild-type GPCR including hNPFFR2/CHO, hKOR/CHO, hMOR/CHO or CHO-K1 cells (insert) were incubated with immune sera collected from mice immunized against the corresponding receptor. Bound IgG were then revealed with Alexa 488-labeled goat anti-mouse IgG antibodies (green staining). Cell nuclei were stained in red with propidium iodide. Fluorescence images were acquired by confocal microscopy. In (c), the binding of immune serum IgG to CHO cells expressing their corresponding receptors was examined by cytofluorometry: hNPFFR2/CHO cells (upper panel), hKOR/CHO cells (middle panel) and hMOR/CHO cells (lower panels). GPCR-expressing CHO cells (grey histogram) and CHO-K1 cells (open histogram) were incubated with immune sera for 30 min at 4uC. Bound IgG were then revealed with biotin-conjugated goat anti-mouse antibodies followed by an additional incubation with allophycocyanin-labeled streptavidin. Backgrounds (dotted line) correspond to GPCRexpressing CHO cells or wild-type CHO-K1 cells stained with normal serum IgG from non-immunized mouse. 
The figure shows one representative experiment out of 3 performed. doi:10.1371/journal.pone.0046348.gSDS-solubilized receptors or reconstituted in Freund’s adjuvant (lyophilized receptor). Taken together, our results show that the methodology developed to produce high amounts of purified GPCRs for structural studies is also valuable to generate highly specific anti-GPCR antibodies. This new strategy, that may be applicable in most laboratories, does not require receptors in native conformation to immunize animals nor an antibody purification step. Moreover, the method offers some other advantages includingAntibodies against G-Protein Coupled ReceptorsFigure 3. Specificity of anti-GPCR serum IgG. (a) Anti-hNPFFR2 IgG binding to deglycosylated hNPFFR2 receptor. Total cell membrane prepared from h.And D-dianhydromannitol monooleate (amphiphilic detergent) within Freund’s adjuvant partially restore receptor structural architecture by mimicking molecular interactions of the lipid bilayer cell membrane with receptors. Thus, polyclonal anti-GPCR IgG antibodies may include both antibodies able to bind to linear epitopes accessible in both native and denatured forms of the receptor and antibodies able to bind to conformational antigenic determinants preserved inDetection of endogenous receptorsThe ability of anti-GPCR IgG antibodies to recognize endogenous receptors was then investigated in human spermatozoids and human SH-SY5Y neuroblastoma cells in which the expression of MOR or KOR is well established [35,36,37]. AsAntibodies against G-Protein Coupled ReceptorsFigure 2. Binding of immune serum IgG to recombinant wild-type GPCRs expressed in CHO cells. The ability of immune serum IgG from mice immunized against hNPFFR2 (upper panels), hKOR (middle panels) and hMOR (lower panels) to specifically bind to their corresponding receptors (i.e. used for immunization) was assessed by western-blotting (a), confocal immunofluorescence microscopy (b), and cytofluorometry (c). In (a), membrane proteins extracted from untransfected CHO-K1 cells (left lanes) or from CHO-K1 cells expressing either hNPFFR2 (hNPFFR2/CHO), hKOR (hKOR/CHO) or hMOR (hMOR/CHO) (right lanes) were run on SDS-polyacrylamide gel and transferred onto PVDF membrane. Protein extracts were probed with corresponding mouse immune sera. Bound IgG were revealed using horseradish peroxidase-labeled rabbit anti-mouse IgG antibodies. In (b), CHO cells expressing wild-type GPCR including hNPFFR2/CHO, hKOR/CHO, hMOR/CHO or CHO-K1 cells (insert) were incubated with immune sera collected from mice immunized against the corresponding receptor. Bound IgG were then revealed with Alexa 488-labeled goat anti-mouse IgG antibodies (green staining). Cell nuclei were stained in red with propidium iodide. Fluorescence images were acquired by confocal microscopy. In (c), the binding of immune serum IgG to CHO cells expressing their corresponding receptors was examined by cytofluorometry: hNPFFR2/CHO cells (upper panel), hKOR/CHO cells (middle panel) and hMOR/CHO cells (lower panels). GPCR-expressing CHO cells (grey histogram) and CHO-K1 cells (open histogram) were incubated with immune sera for 30 min at 4uC. Bound IgG were then revealed with biotin-conjugated goat anti-mouse antibodies followed by an additional incubation with allophycocyanin-labeled streptavidin. Backgrounds (dotted line) correspond to GPCRexpressing CHO cells or wild-type CHO-K1 cells stained with normal serum IgG from non-immunized mouse. The figure shows one representative experiment out of 3 performed. doi:10.1371/journal.pone.0046348.gSDS-solubilized receptors or reconstituted in Freund’s adjuvant (lyophilized receptor). Taken together, our results show that the methodology developed to produce high amounts of purified GPCRs for structural studies is also valuable to generate highly specific anti-GPCR antibodies. This new strategy, that may be applicable in most laboratories, does not require receptors in native conformation to immunize animals nor an antibody purification step. Moreover, the method offers some other advantages includingAntibodies against G-Protein Coupled ReceptorsFigure 3. Specificity of anti-GPCR serum IgG. (a) Anti-hNPFFR2 IgG binding to deglycosylated hNPFFR2 receptor. Total cell membrane prepared from h.